期刊文献+

老年糖尿病患者血清褪黑素水平和白细胞诱导型一氧化氮合酶mRNA的表达 被引量:1

Serum melatonin levels and expression of inducible nitric oxide synthase mRNA in leucocytes of elderly diabetic patients
原文传递
导出
摘要 对70例新诊断的糖尿病患者和30例老年健康者(对照组),检测空腹血清褪黑素及外周血白细胞中诱导型一氧化氮合酶(iNOS)mRNA表达水平.老年起病的糖尿病患者(37例)的血清褪黑素水平明显低于对照组[(6.6±1.3)与(7.7±1.4)ng/L,P<0.01];外周血白细胞iNOS mRNA表达水平明显高于成年起病的糖尿病患者[(36±3)%与(30±4)%,P<0.01],对照组无iNOS mRNA表达.多元logistic回归分析显示,血清褪黑素水平下降及外周血白细胞中iNOS mRNA表达水平增高,可能是老年人发生糖尿病的危险因素. Seventy newly diagnosed diabetic patients were enrolled in the study, including 37patients aged over 60 (elderly-onset diabetes, EOD group) and 33 patients under 60 (adult-onset diabetes,AOD group) ; 30 elderly healthy subjects served as controls. Serum melatonin levels were determined with ELISA and the expression of inducible nitric oxide synthase (iNOS) mRNA in peripheral blood leucocytes (PBL) was detected by reverse transcription polymerase chain reaction (RT-PCR). The results showed that serum melatonin levels were significantly lower in EOD group than those in control group [ (6. 6 ± 1.3 )ng/L vs. (7.7 ± 1.4) ng/L, P 〈0. 01 ], the expression of iNOS mRNA was significantly higher than that in AOD group [ (36 ± 3 )% vs. (30 ± 4)%, P 〈 0. 01 ]; and i NOS mRNA was not detected in control group.Logistic regression analysis indicated that decreased serum melatonin levels and up-regulated iNOS mRNA might be independent risk factors for diabetes mellitus in the elderly.
出处 《中华全科医师杂志》 2011年第3期192-194,共3页 Chinese Journal of General Practitioners
基金 基金项目:山东省医药卫生科研项目(2007BZ01)
关键词 糖尿病 2型 褪黑激素 Diabetes mellitus, type 2 Melatonin
  • 相关文献

参考文献9

  • 1Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res, 2008, 44 ( 1 ) : 26-40.
  • 2Wakabayashi I, Nakano T, Takahashi Y. Enhancement of intedeukin-lbeta-induced iNOS expression in cultured vascular smooth muscle cells of Goto-Kakizaki diabetes rats. Eur J Pharmaco1,2010,629 ( 1-3 ) : 1-6.
  • 3Kurcer Z, Parlakpinar H, Vardi N, et al. Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes ,2007,115 : 365-371.
  • 4Escames G, Lopez LC, Tapias V, et al. Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res, 2006, 40:71-78.
  • 5Ha E, Yim SV, Chung JH, et al. Melatonin stimulates glucose transpor~ via insulin receptor substrate-1/phosphatidylinositol 3- kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res, 2006, 41 : 67-72.
  • 6Peschke E, Frese T, Chankiewitz E, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res, 2006,40 : 135-143.
  • 7Penfornis P, Marette A. Inducible nitric oxide synthase modulates lipolysis in Adipocytes. J Lipid Res,2005, 46: 135-142.
  • 8Kolodziejska KE, Burns AR, Moore RH, et al. Regulation of inducible nitric oxide synthase by aggresome formation. Proc Natl Acad Sci U S A, 2005, 102: 4854-4859.
  • 9Charbonneau A, Marette A. Inducible nitric oxide syntbase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes, 2010, 59: 861-871.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部